Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BEVC
Berkeley, California, USAbevc.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
BEVC was founded in 2023 in Berkeley, California by three women with deep backgrounds in life sciences and venture capital. The firm focuses on investing at the intersection of human health and planetary health—expanding from traditional life science investments to include climate tech. Its first two portfolio companies are Radar Therapeutics and Insamo. The company has announced plans to raise a $25 million fund for these purposes. Its advisory board includes Nobel laureates Jennifer Doudna and Carolyn Bertozzi as well as other prominent scientists. No clinical results or pipeline data apply since it does not develop therapeutics itself.
- Industry
- Investors
Beyond the preview
Go deeper on BEVC.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BEVC.